Sky News
@skynews·9.3M subscribers·76.1K videos
Alzheimer's drug Lecanemab approved in UK - but will not be available on NHS
Posted
August 22, 2024
Views
6,586
Likes
67
Comments
27
Engagement
1.43%
August 22, 2024
6,586
67
27
1.43%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
2:18Now PlayingA drug that can slow the symptoms of Alzheimer's has been approved by the UK's medicines regulator.
Lecanemab has been given the green light for use in Britain after being found to delay the progression of the condition by between four and six months.
However, it will not be rolled out on the NHS, with a health service watchdog ruling it is not cost effective.
#skynews #alzheimers #health #uk
SUBSCRIBE to our YouTube channel for more videos
Follow us on Twitter
Like us on Facebook
Follow us on Instagram
Follow us on TikTok
For more content go to and download our appsApple Android
Sky News Daily podcast is available for free here
Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí
To enquire about licensing Sky News content, you can find more information here
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
